Drug Affordability: The High Cost of Healing
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?
In this podcast episode, we untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.
Guests include:
- Peter Kolchinsky, Founder and Managing Partner at RA Capital
- Gunnar Esiason, Head of Patient Engagement at RAVen (RA Ventures)
- Dean Dimizas, Partner in the Private Client Practice at Cambridge Associates
Listen below or wherever you get your podcasts.
Explore more episodes
Listen nowAbout Unseen Upside: Investments Beyond Their Returns
Today’s investment decisions drive tomorrow’s innovations. Through conversations with investors and entrepreneurs, discover how strategic investments can impact our lives in unexpected ways. Powered by the network of Cambridge Associates, host Hillary Ribaudo explores the investments being made that will redefine our future. Join us to uncover the Unseen Upside.
Our podcast is developed in partnership with PRX, an award-winning podcast media company. In 2024, Unseen Upside was named a Best Branded Podcast Honoree by the 28th Annual Webby Awards and won the International Women’s Podcast Awards for a “A Moment of Visionary Leadership.”
Enjoying the podcast? Subscribe, rate, and review on Apple Podcasts and Spotify. Have an idea or want to be a guest? Email unseenupside@cambridgeassociates.com.
About Cambridge Associates
Cambridge Associates is a global investment firm serving endowments, foundations, healthcare systems, pension plans, private clients, and family offices to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. We deliver a range of portfolio management services, including outsourced CIO (OCIO), non-discretionary portfolio management, staff extension, and asset class mandates. Learn more about us.